References
- Waldmann TA. Protein-losing enteropathy. Gastroenterology 1966; 50: 422–43
- Vignes S, Bellanger J. Primary intestinal lymphangiectasia (Waldmann's disease). Orphanet J Rare Dis 2008; 3: 5
- Strober W, Wochner RD, Carbone PP, Waldmann TA. Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection. J Clin Invest 1967; 46: 1643–56
- Weiden PL, Blaese RM, Strober W, Block JB, Waldmann TA. Impaired lymphocyte transformation in intestinal lymphangiectasia: evidence for at least two functionally distinct lymphocyte populations in man. J Clin Invest 1972; 51: 1319–25
- Heresbach D, Raoul JL, Genetet N, Noret P, Siproudhis L, Ramee MP, et al. Immunological study in primary intestinal lymphangiectasia. Digestion 1994; 55: 59–64
- Muller C, Wolf H, Göttlicher J, Zielinski CC, Eibl MM. Cellular immunodeficiency in protein-losing enteropathy. Predominant reduction of CD3+ and CD4+ lymphocytes. Dig Dis Sci 1991; 36: 116–22
- Fuss IJ, Strober W, Cuccherini BA, Pearlstein GR, Bossuyt X, Brown M, et al. Intestinal lymphangiectasia, a disease characterized by selective loss of naïve CD45RA+ lymphocytes into the gastrointestinal tract. Eur J Immunol 1998; 28: 4275–85
- Yamamoto H, Tsutsui T, Mayumi M, Kasakura S. Immunodeficiency associated with selective loss of helper/inducer T cells and hypogammaglobulinaemia in a child with intestinal lymphangiectasia. Clin Exp Immunol 1989; 75: 196–200
- Sorensen RU, Halpin TC, Abramowsky CR, Hornick DL. Intestinal lymphangiectasia and thymic hypoplasia. Clin Exp Immunol 1985; 59: 217–26
- Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 1999; 17: 331–67
- Siegel RM, Chan FK, Chun HJ, Lenardo MJ. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol 2000; 1: 469–74
- Bouhnik Y, Etienney I, Nemeth J, Thevenot T, Lavergne-Slove A, Matuchansky C. Very late onset small intestinal B cell lymphoma associated with primary intestinal lymphangiectasia and diffuse cutaneous warts. Gut 2000; 47: 296–300
- Ward M, Le Roux A, Small WP, Sircus W. Malignant lymphoma and extensive viral wart formation in a patient with intestinal lymphangiectasia and lymphocyte depletion. Postgrad Med J 1977; 53: 753–7
- Bliss CM, Schroy PC III. Primary intestinal lymphangiectasia. Curr Treat Options Gastroenterol 2004; 7: 3–6
- Ballinger AB, Farthing MJ. Octreotide in the treatment of intestinal lymphangiectasia. Eur J Gastroenterol Hepatol 1998; 10: 699–702
- Persic M, Browse NL, Prpic I. Intestinal lymphangiectasia and protein losing enteropathy responding to small bowel restriction. Arch Dis Child 1998; 78: 194